7775 · DAIKEN MEDICAL CO.,LTD · Financials
Market Cap
11.81B JPY
Shares
28.73M
Volume · Nov 13
54K
Avg daily vol (3M)
30.53K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
10.29B
+3.4%
FY2026
Net Income
922.64M
-15.9%
FY2026
Gross Margin
38.4%
-2.8pp
FY2026
Operating Margin
12.41%
-2.8pp
FY2026
Operating Cash Flow
567.71M
-49.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 10.29B | 9.95B | 9.75B | 9.14B | 8.54B |
| JPY | 6.34B | 5.85B | 5.77B | 5.61B | 4.86B |
| JPY | 3.95B | 4.1B | 3.98B | 3.53B | 3.68B |
| JPY | 1.28B | 1.51B | 1.44B | 1.05B | 1.15B |
| JPY | 1.25B | 1.51B | 1.44B | 1.03B | 1.15B |
| JPY | 323.47M | 410.81M | 447.86M | 312.96M | 320.28M |
| JPY | 922.64M | 1.1B | 988.6M | 712.06M | 831.06M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 2.99B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.